With the identification of key Musashi/NUMB pathway proteins in normal colonic SCs, how they are aberrantly expressed in CRC cells and how they respond to ATRA treatment provides insight into the design of targeted anti-SC therapies that are more effective and beneficial to patients. The gene discussed is NUMB; the disease is colorectal carcinoma.